Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.681673094100793e-75,88.920892494929,15309.873995156891,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS28', 'RPS27', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS23']",6.104473331585879e-73,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.504479002271167e-08,5.644870055317816,98.79990271020645,"['COX8A', 'NDUFA7', 'NDUFA4', 'COX4I1', 'NDUFA2', 'NDUFA1', 'ATP5MC3', 'NDUFC2', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7A1', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX7A2L', 'NDUFAB1', 'UQCRFS1']",4.545629389122168e-06,0,0,19
3,Mitochondrial CIV Assembly WP4922,1.3044594450930287e-06,9.36972379313171,126.95715093954958,"['COX8A', 'COA3', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX14', 'COX6A1', 'COX5B', 'COX6C', 'PET117']",0.00015783959285625647,0,0,10
4,Nonalcoholic fatty liver disease WP4396,1.3025513277170402e-05,3.489300051800052,39.24974253073004,"['COX8A', 'NDUFA7', 'NDUFA4', 'COX4I1', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'IRS2', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7A1', 'UQCRH', 'SOCS3', 'COX7A2L', 'NDUFAB1', 'UQCRFS1', 'CCL2']",0.001182065329903214,0,0,19
5,Vitamin D Receptor Pathway WP2877,5.493229719619463e-05,4.544041450777202,44.57436151738307,"['CDKN2D', 'CDKN1A', 'BCL6', 'GADD45A', 'HILPDA', 'CREG2', 'S100A6', 'SPP1', 'PRKCQ', 'ATP2C2', 'JUNB', 'CD200']",0.00398808477644373,0,0,12
6,Spinal Cord Injury WP2431,0.00011784907991089782,4.143623306972094,37.48365456461915,"['LGALS3', 'ZFP36', 'GAP43', 'IL1R1', 'COL4A1', 'GADD45A', 'CCL2', 'SLIT3', 'MIF', 'AQP1', 'ICAM1', 'GFAP']",0.007129869334609318,0,0,12
7,Calcium Regulation in the Cardiac Cell WP536,0.0006549340454742621,2.9962700625423855,21.965583981931424,"['CHRM3', 'RYR2', 'YWHAB', 'CACNA1D', 'ATP1B1', 'PRKCZ', 'RGS4', 'GNG3', 'GNG2', 'PRKAR2B', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.033963008358165306,0,0,14
8,Selenium Micronutrient Network WP15,0.0010128370340908269,4.476549865229111,30.86581105752212,"['SERPINA3', 'PRDX5', 'RFK', 'CCL2', 'SOD2', 'ICAM1', 'SELENOH', 'SOD1']",0.04595748042187127,0,0,8
9,Folate Metabolism WP176,0.0016639904265546943,5.583394383394383,35.72555381617471,"['SERPINA3', 'RFK', 'CCL2', 'SOD2', 'ICAM1', 'SOD1']",0.067114280537706,0,0,6
10,Myometrial relaxation and contraction pathways WP289,0.0020071754297665743,2.747330431223723,17.063742947874108,"['RYR2', 'OXTR', 'YWHAB', 'PRKCZ', 'RGS4', 'ACTA2', 'GNG3', 'GNG2', 'PRKAR2B', 'PRKCQ', 'CALM3', 'YWHAG', 'YWHAH']",0.07286046810052664,0,0,13
11,Vitamin B12 metabolism WP1533,0.0023444644128081944,6.506257110352673,39.39993011316346,"['SERPINA3', 'CCL2', 'SOD2', 'ICAM1', 'SOD1']",0.07736732562267042,0,0,5
12,Genotoxicity pathway WP4286,0.003465409255064902,4.025634568896051,22.80491606720757,"['ACTA2', 'ITPKC', 'CDKN1A', 'RPS27', 'CEBPD', 'GADD45A', 'TRIM22']",0.08885020421660184,0,0,7
13,Complement system WP2806,0.0035038116302862133,4.688410256410257,26.507820873329003,"['RPS19', 'C1R', 'PROS1', 'SPP1', 'SERPING1', 'ICAM1']",0.08885020421660184,0,0,6
14,Dual hijack model of Vif in HIV infection WP3300,0.0035468213585365276,14.603316326530612,82.38758037185471,"['UBB', 'ELOB', 'RUNX1']",0.08885020421660184,0,0,3
15,Type II interferon signaling (IFNG) WP619,0.0036714960420083406,5.739811282874925,32.18401761288805,"['SOCS3', 'CIITA', 'GBP1', 'ICAM1', 'PSMB9']",0.08885020421660184,0,0,5
16,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.005469162430648495,11.681632653061225,60.84529988878315,"['CDKN1A', 'SPP1', 'FAM20C']",0.12408162264533773,0,0,3
17,GABA receptor Signaling WP4159,0.006560496229888544,4.877559726962457,24.51797599262647,"['GABRA1', 'GAD1', 'AP2S1', 'GABRD', 'GABRG3']",0.14008589008526715,0,0,5
18,Adipogenesis WP236,0.008530881063172737,2.6111302352266206,12.439587983211688,"['SOCS3', 'CDKN1A', 'KLF6', 'GADD45B', 'CEBPD', 'GADD45A', 'NAMPT', 'ID3', 'IRS2', 'MIF']",0.17203943477398354,0,0,10
19,Oxidative phosphorylation WP623,0.010538173858394319,3.1805511309334182,14.480257370840825,"['NDUFA7', 'NDUFA4', 'NDUFA2', 'NDUFAB1', 'NDUFC2', 'ATP5MC3', 'ATP5MC1']",0.1976241880962804,0,0,7
20,IL1 and megakaryocytes in obesity WP2865,0.010888385019078812,8.342565597667638,37.70888581359053,"['IL1R1', 'CCL2', 'ICAM1']",0.1976241880962804,0,0,3
21,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.011713136807719599,3.1079934620174345,13.821384494621881,"['CDKN1A', 'SHC1', 'TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.20246993624772447,0,0,7
22,"GPCRs, Other WP117",0.012342333088992583,5.196138557637706,22.83557513942807,"['CHRM3', 'EDNRA', 'GRM1', 'ADGRL2']",0.2036484959683776,0,0,4
23,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.014389489694191853,3.9003412969283278,16.54235069090477,"['GABRA1', 'SLC12A5', 'SHC1', 'GABRD', 'GABRG3']",0.22710368517354967,0,0,5
24,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.02325649506696053,5.838265306122449,21.95871315693177,"['EGF', 'SPP1', 'SOD1']",0.3488295533994254,0,0,3
25,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.02402407392558026,2.9264102564102563,10.91170261960013,"['CDKN1A', 'CEBPD', 'WNT7B', 'SPP1', 'JUNB', 'HES5']",0.3488295533994254,0,0,6
26,Signal transduction through IL1R WP4496,0.02790037619592444,3.8954003407155025,13.94208620540125,"['IL1R1', 'TOLLIP', 'IL1RAP', 'MAP3K14']",0.3895321753507912,0,0,4
27,VEGFA-VEGFR2 Signaling Pathway WP3888,0.02952566721373937,1.5414543128265275,5.429765601214592,"['RPL5', 'SHC1', 'ARPC5L', 'RPL10A', 'PRKCZ', 'NDRG1', 'APOLD1', 'RPL7', 'ICAM1', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'AP2S1', 'CCL2', 'ATP6V1E1', 'IER5', 'TMSB10', 'RPS6', 'RPL13A', 'SOD2', 'TXNIP', 'RPL27', 'RPL26', 'HSPA1A', 'EPHA2']",0.39695619254027376,0,0,26
28,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.03160810489870134,9.719015280135823,33.57279983450009,"['SOCS3', 'CHI3L1']",0.4054825798465017,0,0,2
29,Cardiac Progenitor Differentiation WP2406,0.03440904029587257,4.8643707482993195,16.390185672620458,"['MESP1', 'NRG1', 'THY1']",0.4054825798465017,0,0,3
30,IL-1 signaling pathway WP195,0.03462798891251117,2.6594405594405592,8.943945918246728,"['IL1R1', 'TOLLIP', 'CCL2', 'IL1RAP', 'PRKCZ', 'MAP3K14']",0.4054825798465017,0,0,6
31,Mitochondrial complex I assembly model OXPHOS system WP4324,0.03462798891251117,2.6594405594405592,8.943945918246728,"['NDUFA7', 'NDUFA2', 'NDUFAB1', 'NDUFA1', 'NDUFC2', 'TMEM70']",0.4054825798465017,0,0,6
32,Proximal tubule transport WP4917,0.03635856141115887,3.540653554282174,11.734878629314958,"['ATP6V1E1', 'ATP1B1', 'AQP1', 'ATP6V1F']",0.4124424310078334,0,0,4
33,Platelet-mediated interactions with vascular and circulating cells WP4462,0.042832641270902284,7.774533106960951,24.49331530431227,"['CCL2', 'ICAM1']",0.45264425351249576,0,0,2
34,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.043219795193429805,2.043934308319348,6.420931058990096,"['RYR2', 'SNAP25', 'GABRA1', 'TSPYL1', 'PRKAR2B', 'YWHAB', 'YWHAG', 'HES5', 'YWHAH']",0.45264425351249576,0,0,9
35,Oncostatin M Signaling Pathway WP2374,0.0442965528498447,2.4890343698854336,7.757942839946897,"['SOCS3', 'SHC1', 'RPS6', 'CCL2', 'OSMR', 'JUNB']",0.45264425351249576,0,0,6
36,Glycolysis and Gluconeogenesis WP534,0.046137293057747504,3.245031232254401,9.982149918023978,"['TPI1', 'MDH1', 'MDH2', 'PGAM1']",0.45264425351249576,0,0,4
37,Prader-Willi and Angelman Syndrome WP3998,0.046137293057747504,3.245031232254401,9.982149918023978,"['SNRPN', 'GABRG3', 'PRKCZ', 'GABRD']",0.45264425351249576,0,0,4
38,Complement and Coagulation Cascades WP558,0.04784444574039061,4.168731778425656,12.672111878485463,"['C1R', 'PROS1', 'SERPING1']",0.4567271934777734,0,0,3
39,Gastric acid production WP2596,0.049069863762074825,inf,inf,['CCK'],0.4567271934777734,0,0,1
40,Cell cycle WP179,0.053405204868950465,2.0541662905118714,6.018393084077076,"['CDKN2D', 'CDKN1A', 'GADD45B', 'GADD45A', 'YWHAB', 'CDC7', 'YWHAG', 'YWHAH']",0.46314665380508396,0,0,8
41,Hippo-Merlin Signaling Dysregulation WP4541,0.0551214762208082,2.167047184170472,6.280570541697733,"['PPP1R14A', 'PRKAR2B', 'CDH12', 'PAK3', 'CDH18', 'CD44', 'EPHA2']",0.46314665380508396,0,0,7
42,Peptide GPCRs WP24,0.05528715516968636,6.4782116581777025,18.75581344656136,"['OXTR', 'EDNRA']",0.46314665380508396,0,0,2
43,CAMKK2  Pathway WP4874,0.05723483603928119,2.9948892674616694,8.56715790953208,"['CHRM3', 'FIS1', 'MAP1LC3A', 'ICAM1']",0.46314665380508396,0,0,4
44,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.058016499577716804,2.5630950242500448,7.297202873723061,"['BEX3', 'SOCS3', 'CDKN1A', 'NRG1', 'YBX3']",0.46314665380508396,0,0,5
45,Synaptic Vesicle Pathway WP2267,0.058016499577716804,2.5630950242500448,7.297202873723061,"['SNAP25', 'RAB3A', 'AP2S1', 'SYP', 'CPLX1']",0.46314665380508396,0,0,5
46,Pyrimidine metabolism WP4022,0.058690760537283365,2.132999785958904,6.048063229455354,"['POLE4', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.46314665380508396,0,0,7
47,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.0634584131679673,3.647002551020408,10.056137241670664,"['BCL6', 'H2AFJ', 'H2AFZ']",0.4799042495827527,0,0,3
48,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.0634584131679673,3.647002551020408,10.056137241670664,"['MDH1', 'MDH2', 'NAMPT']",0.4799042495827527,0,0,3
49,Disruption of postsynaptic signaling by CNV WP4875,0.06962974106115957,2.7804818690679,7.408770469636842,"['RPH3A', 'RYR2', 'GRM1', 'YWHAG']",0.5158284899020597,0,0,4
50,Oxidative Stress WP408,0.07203782320968008,3.432172869147659,9.028550307415545,"['SOD2', 'JUNB', 'SOD1']",0.5228281510816727,0,0,3
51,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.07345519478006972,2.3749271622409056,6.201123991802378,"['IL1R1', 'TOLLIP', 'IRF7', 'IL1RAP', 'MAP3K14']",0.5228281510816727,0,0,5
52,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.07905244120712206,2.3181781244921176,5.882710423714795,"['RYR2', 'ACTN1', 'CACNA1D', 'CACNG2', 'DSC2']",0.5305426324659812,0,0,5
53,Ectoderm Differentiation WP2858,0.07956297525763022,1.7917630969913738,4.535322270878108,"['CLDN11', 'TRPM2', 'ELOVL4', 'PODXL', 'ARHGDIG', 'CCL2', 'SORCS1', 'LY6E', 'SNCA']",0.5305426324659812,0,0,9
54,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.08110433393206837,3.241213151927438,8.14198863151572,"['RAB3A', 'NEFL', 'NDRG1']",0.5305426324659812,0,0,3
55,Prolactin Signaling Pathway WP2037,0.08258673454959234,2.0873626373626375,5.205686643894448,"['SOCS3', 'SHC1', 'RPS6', 'IRS2', 'PPIA', 'YWHAG']",0.5305426324659812,0,0,6
56,Serotonin and anxiety WP3947,0.08330834724672433,4.8578098471986415,12.072660743002249,"['GABRA1', 'GRM1']",0.5305426324659812,0,0,2
57,Osteopontin Signaling WP1434,0.08330834724672433,4.8578098471986415,12.072660743002249,"['SPP1', 'MAP3K14']",0.5305426324659812,0,0,2
58,TP53 network WP1742,0.09861400778542966,4.3176759102056215,10.002077418585781,"['CDKN1A', 'GADD45A']",0.577369110098564,0,0,2
59,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.09861400778542966,4.3176759102056215,10.002077418585781,"['RYR2', 'CCK']",0.577369110098564,0,0,2
60,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.09861400778542966,4.3176759102056215,10.002077418585781,"['RPH3A', 'SYTL4']",0.577369110098564,0,0,2
61,Fatty acid transporters WP5061,0.09861400778542966,4.3176759102056215,10.002077418585781,"['FABP3', 'FABP5']",0.577369110098564,0,0,2
62,Leptin Insulin Overlap WP3935,0.09861400778542966,4.3176759102056215,10.002077418585781,"['SOCS3', 'IRS2']",0.577369110098564,0,0,2
63,Lung fibrosis WP3624,0.10060624151503722,2.9165816326530614,6.698049241918221,"['EGF', 'SPP1', 'CCL2']",0.5796835820628335,0,0,3
64,Pathways Regulating Hippo Signaling WP4540,0.10986216417176467,1.9154266498528794,4.230274828357511,"['PRKAR2B', 'CDH12', 'PRKCQ', 'PRKCZ', 'CDH18', 'EPHA2']",0.6231244624117277,0,0,6
65,Cori Cycle WP1946,0.11462612551783043,3.8855687606112053,8.416450952137815,"['TPI1', 'PGAM1']",0.6401428240457299,0,0,2
66,Oxidative Damage WP3941,0.13290984625944513,2.5354924578527065,5.116837340106144,"['CDKN1A', 'C1R', 'GADD45A']",0.7310041544269482,0,0,3
67,MECP2 and Associated Rett Syndrome WP3584,0.13896804061645682,1.9075821454861808,3.7646349119942535,"['RBFOX1', 'CEBPD', 'BCL6', 'GAD1', 'RPS6']",0.7479693826975801,0,0,5
68,COVID-19 adverse outcome pathway WP4891,0.1401154766485825,9.704237288135593,19.071624615683596,['CCL2'],0.7479693826975801,0,0,1
69,Senescence and Autophagy in Cancer WP615,0.147864661294846,1.742977420589361,3.3316279153015547,"['GABARAPL1', 'CDKN1A', 'MAP1LC3A', 'IFI16', 'IRF7', 'CD44']",0.7584899321742936,0,0,6
70,Transcription factor regulation in adipogenesis WP3599,0.14835478012224476,3.2374080362195814,6.1774559707807555,"['CEBPD', 'IRS2']",0.7584899321742936,0,0,2
71,ERK Pathway in Huntington's Disease WP3853,0.14835478012224476,3.2374080362195814,6.1774559707807555,"['EGF', 'GRM1']",0.7584899321742936,0,0,2
72,The influence of laminopathies on Wnt signaling WP4844,0.15617839429910077,2.3322448979591837,4.330410575098655,"['CEBPD', 'SPP1', 'HES5']",0.7640615001213455,0,0,3
73,Glucocorticoid Receptor Pathway WP2880,0.15858454677824202,1.994321408290744,3.672477877879166,"['GADD45B', 'ENC1', 'CCL2', 'ANGPTL4']",0.7640615001213455,0,0,4
74,IL-4 signaling pathway WP395,0.15858454677824202,1.994321408290744,3.672477877879166,"['SOCS3', 'NFIL3', 'SHC1', 'IRS2']",0.7640615001213455,0,0,4
75,G Protein Signaling Pathways WP35,0.161701141683829,1.6921590486807878,3.0831230122086817,"['GNG3', 'PRKAR2B', 'PRKCQ', 'AKAP5', 'PDE8B', 'PRKCZ']",0.7640615001213455,0,0,6
76,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.16588490199324163,2.9881154499151106,5.368033145964464,"['ACTN1', 'PRKCQ']",0.7640615001213455,0,0,2
77,Mitochondrial complex III assembly WP4921,0.16588490199324163,2.9881154499151106,5.368033145964464,"['UQCRFS1', 'UQCRH']",0.7640615001213455,0,0,2
78,Nucleotide metabolism WP404,0.16588490199324163,2.9881154499151106,5.368033145964464,"['NME2', 'OAZ1']",0.7640615001213455,0,0,2
79,Metapathway biotransformation Phase I and II WP702,0.17607018825451162,1.6442036836403033,2.855772271921651,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'SULT4A1', 'HS6ST3']",0.7640615001213455,0,0,6
80,Cells and molecules involved in local acute inflammatory response  WP4493,0.1823205306665083,6.468926553672317,11.01004172888071,['ICAM1'],0.7640615001213455,0,0,1
81,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.1823205306665083,6.468926553672317,11.01004172888071,['CDKN1A'],0.7640615001213455,0,0,1
82,Nuclear Receptors Meta-Pathway WP2882,0.18851903379729473,1.3673908432566737,2.2815686090041067,"['GADD45B', 'SLC6A15', 'ENC1', 'CCL2', 'IRS2', 'NRG1', 'ANGPTL4', 'JUNB', 'SLC5A3', 'SLC39A14', 'EPHA2', 'HSPA1A']",0.7640615001213455,0,0,12
83,Aryl Hydrocarbon Receptor Netpath WP2586,0.1931593303882364,2.0818148688046647,3.4230030396417965,"['CDKN1A', 'KLF6', 'PSRC1']",0.7640615001213455,0,0,3
84,Globo Sphingolipid Metabolism WP1424,0.20186791563698794,2.589247311827957,4.143162539446866,"['ST6GAL1', 'A4GALT']",0.7640615001213455,0,0,2
85,Kallmann's Syndrome WP5074,0.20186791563698794,2.589247311827957,4.143162539446866,"['SEMA3E', 'PRKCQ']",0.7640615001213455,0,0,2
86,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.20186791563698794,2.589247311827957,4.143162539446866,"['UGCG', 'GALNT16']",0.7640615001213455,0,0,2
87,Amyotrophic lateral sclerosis (ALS) WP2447,0.20593825581068212,2.0098522167487687,3.1759260332582158,"['NEFL', 'NEFH', 'SOD1']",0.7640615001213455,0,0,3
88,Hepatitis C and Hepatocellular Carcinoma WP3646,0.20593825581068212,2.0098522167487687,3.1759260332582158,"['CDKN1A', 'PODXL', 'CD44']",0.7640615001213455,0,0,3
89,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.20593825581068212,2.0098522167487687,3.1759260332582158,"['IFITM3', 'IFITM2', 'JUNB']",0.7640615001213455,0,0,3
90,Ferroptosis WP4313,0.21890186560670208,1.942687074829932,2.9511976192748883,"['MAP1LC3A', 'CP', 'SLC39A14']",0.7640615001213455,0,0,3
91,IL-2 signaling pathway WP49,0.21890186560670208,1.942687074829932,2.9511976192748883,"['SOCS3', 'SHC1', 'RPS6']",0.7640615001213455,0,0,3
92,Urea cycle and associated pathways WP4595,0.22017797831895441,2.427207130730051,3.6731388312902875,"['MDH1', 'MDH2']",0.7640615001213455,0,0,2
93,Differentiation Pathway WP2848,0.22017797831895441,2.427207130730051,3.6731388312902875,"['EGF', 'WNT7B']",0.7640615001213455,0,0,2
94,Gastric Cancer Network 2 WP2363,0.22017797831895441,2.427207130730051,3.6731388312902875,"['S100A6', 'CACYBP']",0.7640615001213455,0,0,2
95,Serotonin Transporter Activity WP1455,0.22245740044712822,4.851271186440678,7.291555941903981,['IL1R1'],0.7640615001213455,0,0,1
96,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.22245740044712822,4.851271186440678,7.291555941903981,['COX8A'],0.7640615001213455,0,0,1
97,miR-517 relationship with ARCN1 and USP1 WP3596,0.22245740044712822,4.851271186440678,7.291555941903981,['CDKN1A'],0.7640615001213455,0,0,1
98,Breast cancer pathway WP4262,0.2268597844375548,1.448429758088021,2.1486342227845716,"['CDKN1A', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'HES5']",0.7640615001213455,0,0,7
99,AGE/RAGE pathway WP2324,0.22926453999364177,1.6898007554995926,2.488871617201157,"['LGALS3', 'SHC1', 'PRKCZ', 'SOD1']",0.7640615001213455,0,0,4
100,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.22926453999364177,1.6898007554995926,2.488871617201157,"['PLCE1', 'CCL2', 'PRKCQ', 'PRKCZ']",0.7640615001213455,0,0,4
101,Regulatory circuits of the STAT3 signaling pathway WP4538,0.22926453999364177,1.6898007554995926,2.488871617201157,"['PTPRT', 'SOCS3', 'STMN1', 'OSMR']",0.7640615001213455,0,0,4
102,NRF2 pathway WP2884,0.2300339181961035,1.4957264957264957,2.1980127294009733,"['SLC6A15', 'NRG1', 'SLC5A3', 'SLC39A14', 'EPHA2', 'HSPA1A']",0.7640615001213455,0,0,6
103,G13 Signaling Pathway WP524,0.23202625854151915,1.879855167873601,2.7462893071231296,"['CFL1', 'ARHGDIG', 'PAK3']",0.7640615001213455,0,0,3
104,EGF/EGFR signaling pathway WP437,0.2367636305172955,1.3574682330376409,1.955694947273036,"['PLSCR1', 'SHC1', 'EGF', 'LIMK2', 'CFL1', 'STMN1', 'AP2S1', 'PLCE1', 'PRKCZ']",0.7640615001213455,0,0,9
105,TYROBP causal network in microglia WP3945,0.23861557690352836,2.284230500349546,3.2730772802767603,"['SPP1', 'IL13RA1']",0.7640615001213455,0,0,2
106,Prostaglandin Synthesis and Regulation WP98,0.23861557690352836,2.284230500349546,3.2730772802767603,"['EDNRA', 'S100A6']",0.7640615001213455,0,0,2
107,p53 transcriptional gene network WP4963,0.23995699309621307,1.6537025626155353,2.3603223369726933,"['CDKN1A', 'GADD45A', 'CCL2', 'ICAM1']",0.7640615001213455,0,0,4
108,"GPCRs, Class A Rhodopsin-like WP455",0.24528820672385757,1.820950255102041,2.5590203724368106,"['CHRM3', 'OXTR', 'EDNRA']",0.7640615001213455,0,0,3
109,Toll-like Receptor Signaling related to MyD88 WP3858,0.2571242177643708,2.157140162233541,2.929819082086531,"['TOLLIP', 'IRF7']",0.7640615001213455,0,0,2
110,IL-6 signaling pathway WP364,0.2586652068670502,1.7656153370439085,2.387501591165108,"['SOCS3', 'SHC1', 'JUNB']",0.7640615001213455,0,0,3
111,Sulfation Biotransformation Reaction WP692,0.26062726852073637,3.880677966101695,5.218207887963497,['SULT4A1'],0.7640615001213455,0,0,1
112,Biogenic Amine Synthesis WP550,0.26062726852073637,3.880677966101695,5.218207887963497,['GAD1'],0.7640615001213455,0,0,1
113,Caloric restriction and aging WP4191,0.26062726852073637,3.880677966101695,5.218207887963497,['NAMPT'],0.7640615001213455,0,0,1
114,Complement Activation WP545,0.26062726852073637,3.880677966101695,5.218207887963497,['C1R'],0.7640615001213455,0,0,1
115,Farnesoid X receptor pathway WP2879,0.26062726852073637,3.880677966101695,5.218207887963497,['IRS2'],0.7640615001213455,0,0,1
116,Genes targeted by miRNAs in adipocytes WP1992,0.26062726852073637,3.880677966101695,5.218207887963497,['TMSB4X'],0.7640615001213455,0,0,1
117,HIF1A and PPARG regulation of glycolysis WP2456,0.26062726852073637,3.880677966101695,5.218207887963497,['TPI1'],0.7640615001213455,0,0,1
118,Insulin signaling in adipocytes (diabetic condition) WP3635,0.26062726852073637,3.880677966101695,5.218207887963497,['RPS6'],0.7640615001213455,0,0,1
119,Insulin signaling in adipocytes (normal condition) WP3634,0.26062726852073637,3.880677966101695,5.218207887963497,['RPS6'],0.7640615001213455,0,0,1
120,Monoamine GPCRs WP58,0.26062726852073637,3.880677966101695,5.218207887963497,['CHRM3'],0.7640615001213455,0,0,1
121,Interleukin-11 Signaling Pathway WP2332,0.27213552187254486,1.7135354141656662,2.230089394524727,"['SOCS3', 'RPS6', 'ICAM1']",0.7640615001213455,0,0,3
122,Tryptophan metabolism WP465,0.2756526271164568,2.0434277544455366,2.633189210563871,"['WARS', 'DHCR24']",0.7640615001213455,0,0,2
123,EPO Receptor Signaling WP581,0.2756526271164568,2.0434277544455366,2.633189210563871,"['SHC1', 'IRS2']",0.7640615001213455,0,0,2
124,miRNAs involvement in the immune response in sepsis WP4329,0.2756526271164568,2.0434277544455366,2.633189210563871,"['IRF7', 'ICAM1']",0.7640615001213455,0,0,2
125,One-carbon metabolism and related pathways WP3940,0.28567821398631305,1.6644314868804664,2.0853482798469916,"['GAD1', 'SOD2', 'SOD1']",0.7640615001213455,0,0,3
126,Pancreatic adenocarcinoma pathway WP4263,0.2877900911626951,1.4285535033125878,1.779297551827306,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PAK3']",0.7640615001213455,0,0,5
127,Hematopoietic Stem Cell Differentiation WP2849,0.29415437621057583,1.9410865874363328,2.3752116903129235,"['CIITA', 'RUNX1']",0.7640615001213455,0,0,2
128,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.29415437621057583,1.9410865874363328,2.3752116903129235,"['NOD1', 'NLRP1']",0.7640615001213455,0,0,2
129,Fragile X Syndrome  WP4549,0.29507313606975144,1.3208205878441281,1.612103839275837,"['GABRA1', 'SHC1', 'GAD1', 'AP2S1', 'AKAP5', 'GABRD', 'GRM1']",0.7640615001213455,0,0,7
130,Transcriptional cascade regulating adipogenesis WP4211,0.29692637614078604,3.2336158192090396,3.926486117127164,['CEBPD'],0.7640615001213455,0,0,1
131,"Cerebral organic acidurias, including diseases WP4519",0.29692637614078604,3.2336158192090396,3.926486117127164,['MDH2'],0.7640615001213455,0,0,1
132,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.29692637614078604,3.2336158192090396,3.926486117127164,['DHCR24'],0.7640615001213455,0,0,1
133,Glial Cell Differentiation WP2276,0.29692637614078604,3.2336158192090396,3.926486117127164,['GAP43'],0.7640615001213455,0,0,1
134,"GPCRs, Class B Secretin-like WP334",0.29692637614078604,3.2336158192090396,3.926486117127164,['ADGRL2'],0.7640615001213455,0,0,1
135,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.29692637614078604,3.2336158192090396,3.926486117127164,['PRKCZ'],0.7640615001213455,0,0,1
136,Osteoclast Signaling WP12,0.29692637614078604,3.2336158192090396,3.926486117127164,['SPP1'],0.7640615001213455,0,0,1
137,Melanoma WP4685,0.30605540120282,1.4657195204268587,1.735395999945657,"['CDKN1A', 'GADD45B', 'GADD45A', 'CALM3']",0.7640615001213455,0,0,4
138,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.30605540120282,1.4657195204268587,1.735395999945657,"['RNF19A', 'HSPA1B', 'SNCA', 'HSPA1A']",0.7640615001213455,0,0,4
139,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.3125875305590634,1.8484921982375293,2.149557511219729,"['ACTA2', 'PRKCQ']",0.7640615001213455,0,0,2
140,Cytosolic DNA-sensing pathway WP4655,0.3129011202106237,1.5741864313292884,1.8289969165064783,"['IRF7', 'POLR2K', 'POLR2L']",0.7640615001213455,0,0,3
141,TNF-alpha signaling pathway WP231,0.31686836103834387,1.3678315627553719,1.5720062156218981,"['RFK', 'CCL2', 'KSR2', 'PRKCZ', 'MAP3K14']",0.7640615001213455,0,0,5
142,Endometrial cancer WP4155,0.31728838827938494,1.4384503754180074,1.6512607315924483,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.7640615001213455,0,0,4
143,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.3265436499364645,1.5326262083780882,1.7153024530530083,"['ELOVL4', 'MSMO1', 'DHCR24']",0.7640615001213455,0,0,3
144,Modulators of TCR signaling and T cell activation WP5072,0.3265436499364645,1.5326262083780882,1.7153024530530083,"['ELOB', 'PRKCQ', 'MAP3K14']",0.7640615001213455,0,0,3
145,Ras signaling WP4223,0.3288550177737049,1.2435540308747857,1.383004066853301,"['GNG3', 'GNG2', 'SHC1', 'PLCE1', 'CALM3', 'KSR2', 'PAK3', 'EPHA2']",0.7640615001213455,0,0,8
146,Autosomal recessive Osteopetrosis pathways WP4788,0.3314462636400308,2.7714285714285714,3.0604597018155957,['SNX10'],0.7640615001213455,0,0,1
147,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3314462636400308,2.7714285714285714,3.0604597018155957,['ELOB'],0.7640615001213455,0,0,1
148,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3314462636400308,2.7714285714285714,3.0604597018155957,['EGF'],0.7640615001213455,0,0,1
149,RAS and bradykinin pathways in COVID-19 WP4969,0.3314462636400308,2.7714285714285714,3.0604597018155957,['SERPING1'],0.7640615001213455,0,0,1
150,Exercise-induced Circadian Regulation WP410,0.34018320723871065,1.4931972789115646,1.6100712659053507,"['RBPMS', 'ERC2', 'ETV6']",0.7640615001213455,0,0,3
151,G1 to S cell cycle control WP45,0.34018320723871065,1.4931972789115646,1.6100712659053507,"['CDKN2D', 'CDKN1A', 'GADD45A']",0.7640615001213455,0,0,3
152,PPAR signaling pathway WP3942,0.34018320723871065,1.4931972789115646,1.6100712659053507,"['FABP3', 'FABP5', 'ANGPTL4']",0.7640615001213455,0,0,3
153,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.34251204794534534,1.1811011621261192,1.2654890040387954,"['EFNA1', 'CDKN1A', 'GNG3', 'GNG2', 'COL4A1', 'EGF', 'RPS6', 'SPP1', 'IRS2', 'OSMR', 'EPHA2']",0.7640615001213455,0,0,11
154,DNA damage response (only ATM dependent) WP710,0.35613608492938265,1.294425483503982,1.336419701208583,"['CDKN1A', 'BCL6', 'SHC1', 'WNT7B', 'SOD2']",0.7640615001213455,0,0,5
155,ErbB signaling pathway WP673,0.35613608492938265,1.294425483503982,1.336419701208583,"['CDKN1A', 'SHC1', 'EGF', 'NRG1', 'PAK3']",0.7640615001213455,0,0,5
156,Apoptosis Modulation and Signaling WP1772,0.3624437273193835,1.3387769488339305,1.3587060517339624,"['IL1R1', 'TOLLIP', 'MAP3K14', 'HSPA1A']",0.7640615001213455,0,0,4
157,Non-small cell lung cancer WP4255,0.3624437273193835,1.3387769488339305,1.3587060517339624,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.7640615001213455,0,0,4
158,Retinoblastoma gene in cancer WP2446,0.3624437273193835,1.3387769488339305,1.3587060517339624,"['CDKN1A', 'H2AFZ', 'STMN1', 'CDC7']",0.7640615001213455,0,0,4
159,Development and heterogeneity of the ILC family WP3893,0.36427399950935807,2.42478813559322,2.4486697493348655,['NFIL3'],0.7640615001213455,0,0,1
160,Dopamine metabolism WP2436,0.36427399950935807,2.42478813559322,2.4486697493348655,['SOD1'],0.7640615001213455,0,0,1
161,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.36427399950935807,2.42478813559322,2.4486697493348655,['PRKCQ'],0.7640615001213455,0,0,1
162,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.36427399950935807,2.42478813559322,2.4486697493348655,['GRM1'],0.7640615001213455,0,0,1
163,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.36427399950935807,2.42478813559322,2.4486697493348655,['PRKCQ'],0.7640615001213455,0,0,1
164,Nicotine Activity on Dopaminergic Neurons WP1602,0.36427399950935807,2.42478813559322,2.4486697493348655,['GNG2'],0.7640615001213455,0,0,1
165,Insulin Signaling WP481,0.3661648071889102,1.195197255574614,1.2007809232133806,"['SOCS3', 'SNAP25', 'SHC1', 'IRS2', 'PRKCQ', 'MAP3K6', 'PRKCZ', 'MAP3K14']",0.7640615001213455,0,0,8
166,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3737387269481436,1.3159703173274044,1.2951757711984087,"['CDKN1A', 'GADD45B', 'DCC', 'GADD45A']",0.7640615001213455,0,0,4
167,7q11.23 copy number variation syndrome WP4932,0.37586021002001885,1.2605824209919774,1.233527784158033,"['SNAP25', 'CFL1', 'ATP5MC3', 'NRG1', 'ATP5MC1']",0.7640615001213455,0,0,5
168,Interferon type I signaling pathways WP585,0.3809214694249427,1.386175898931001,1.3378843613156222,"['SOCS3', 'RPS6', 'IRS2']",0.7640615001213455,0,0,3
169,IL17 signaling pathway WP2112,0.3849350290840683,1.5521901528013582,1.481846004210921,"['CEBPD', 'MAP3K14']",0.7640615001213455,0,0,2
170,Intraflagellar transport proteins binding to dynein WP4532,0.3849350290840683,1.5521901528013582,1.481846004210921,"['DYNLT3', 'DYNLL2']",0.7640615001213455,0,0,2
171,Lipid Metabolism Pathway WP3965,0.3849350290840683,1.5521901528013582,1.481846004210921,"['PRKAR2B', 'HILPDA']",0.7640615001213455,0,0,2
172,TCA cycle in senescence WP5050,0.39549239842427253,2.1551789077212806,1.999195058674621,['MDH1'],0.7640615001213455,0,0,1
173,Computational Model of Aerobic Glycolysis WP4629,0.39549239842427253,2.1551789077212806,1.999195058674621,['TPI1'],0.7640615001213455,0,0,1
174,FOXA2 pathway WP5066,0.39549239842427253,2.1551789077212806,1.999195058674621,['IRS2'],0.7640615001213455,0,0,1
175,Galanin receptor pathway WP4970,0.39549239842427253,2.1551789077212806,1.999195058674621,['CDKN1A'],0.7640615001213455,0,0,1
176,Ganglio Sphingolipid Metabolism WP1423,0.39549239842427253,2.1551789077212806,1.999195058674621,['ST8SIA5'],0.7640615001213455,0,0,1
177,ID signaling pathway WP53,0.39549239842427253,2.1551789077212806,1.999195058674621,['ID3'],0.7640615001213455,0,0,1
178,Matrix Metalloproteinases WP129,0.39549239842427253,2.1551789077212806,1.999195058674621,['MMP17'],0.7640615001213455,0,0,1
179,miR-509-3p alteration of YAP1/ECM axis WP3967,0.39549239842427253,2.1551789077212806,1.999195058674621,['EDNRA'],0.7640615001213455,0,0,1
180,miRNAs involved in DNA damage response WP1545,0.39549239842427253,2.1551789077212806,1.999195058674621,['CDKN1A'],0.7640615001213455,0,0,1
181,"NAD metabolism, sirtuins and aging WP3630",0.39549239842427253,2.1551789077212806,1.999195058674621,['NAMPT'],0.7640615001213455,0,0,1
182,Overview of nanoparticle effects WP3287,0.39549239842427253,2.1551789077212806,1.999195058674621,['COL4A1'],0.7640615001213455,0,0,1
183,Alpha 6 Beta 4 signaling pathway WP244,0.4025316884058867,1.4923599320882852,1.3580198642713779,"['SHC1', 'IRS2']",0.7640615001213455,0,0,2
184,Bladder cancer WP2828,0.4025316884058867,1.4923599320882852,1.3580198642713779,"['CDKN1A', 'EGF']",0.7640615001213455,0,0,2
185,Alzheimer's disease WP2059,0.4074909375808589,1.2519646095510248,1.1239344338877617,"['CACNA1D', 'CALM3', 'SNCA', 'CDK5R1']",0.7640615001213455,0,0,4
186,Cardiac Hypertrophic Response WP2795,0.40778234790475343,1.3229359925788498,1.1867023035539999,"['EGF', 'NRG1', 'MAP3K14']",0.7640615001213455,0,0,3
187,Gastrin signaling pathway WP4659,0.41523467926522956,1.1979100830067837,1.052856859726321,"['CDKN1A', 'SHC1', 'RPS6', 'PRKCQ', 'CD44']",0.7640615001213455,0,0,5
188,ATM Signaling Pathway WP2516,0.41988557671987675,1.4369615795761805,1.2469565200014094,"['CDKN1A', 'GADD45A']",0.7640615001213455,0,0,2
189,DNA damage response WP707,0.42108351124694904,1.293424036281179,1.118713621746101,"['CDKN1A', 'GADD45B', 'GADD45A']",0.7640615001213455,0,0,3
190,Kit receptor signaling pathway WP304,0.42108351124694904,1.293424036281179,1.118713621746101,"['SHC1', 'RPS6', 'JUNB']",0.7640615001213455,0,0,3
191,MAPK Signaling Pathway WP382,0.42312323804029184,1.1092205556921564,0.9540315037689169,"['IL1R1', 'GADD45A', 'EGF', 'STMN1', 'CACNA1D', 'MAP3K6', 'CACNG2', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.7640615001213455,0,0,10
192,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4238634561430205,1.1416196615632555,0.9799022874798022,"['RAB3A', 'SHC1', 'CFL1', 'RPS6', 'SPP1', 'IRS2', 'CDK5R1']",0.7640615001213455,0,0,7
193,Alanine and aspartate metabolism WP106,0.42518022871766337,1.9394915254237288,1.6587348679324256,['GAD1'],0.7640615001213455,0,0,1
194,Tryptophan catabolism leading to NAD+ production WP4210,0.42518022871766337,1.9394915254237288,1.6587348679324256,['NAMPT'],0.7640615001213455,0,0,1
195,Type II diabetes mellitus WP1584,0.42518022871766337,1.9394915254237288,1.6587348679324256,['PRKCZ'],0.7640615001213455,0,0,1
196,GDNF/RET signaling axis WP4830,0.42518022871766337,1.9394915254237288,1.6587348679324256,['ROBO2'],0.7640615001213455,0,0,1
197,GPR40 Pathway WP3958,0.42518022871766337,1.9394915254237288,1.6587348679324256,['PLCE1'],0.7640615001213455,0,0,1
198,Hypertrophy Model WP516,0.42518022871766337,1.9394915254237288,1.6587348679324256,['IL1R1'],0.7640615001213455,0,0,1
199,Imatinib and Chronic Myeloid Leukemia WP3640,0.42518022871766337,1.9394915254237288,1.6587348679324256,['GADD45A'],0.7640615001213455,0,0,1
200,Kynurenine Pathway and links to Cellular Senescence WP5044,0.42518022871766337,1.9394915254237288,1.6587348679324256,['CDKN1A'],0.7640615001213455,0,0,1
201,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.42518022871766337,1.9394915254237288,1.6587348679324256,['MAP3K14'],0.7640615001213455,0,0,1
202,RalA downstream regulated genes WP2290,0.42518022871766337,1.9394915254237288,1.6587348679324256,['YBX3'],0.7640615001213455,0,0,1
203,TGF-beta Signaling Pathway WP366,0.4291405933406721,1.1527798933739528,0.9752180022063377,"['CDKN1A', 'KLF6', 'SHC1', 'LIMK2', 'JUNB', 'PJA1']",0.7673794846436649,0,0,6
204,Type 2 papillary renal cell carcinoma WP4241,0.43697814034930416,1.385520252243512,1.1470335708231294,"['CDKN1A', 'ELOB']",0.773771048520963,0,0,2
205,DNA Replication WP466,0.43697814034930416,1.385520252243512,1.1470335708231294,"['CDC7', 'UBA52']",0.773771048520963,0,0,2
206,Regulation of Actin Cytoskeleton WP51,0.44672136896076026,1.1301966641772467,0.9107353182202981,"['CHRM3', 'EGF', 'ACTN1', 'TMSB4X', 'CFL1', 'PAK3']",0.7837557366458314,0,0,6
207,miRNA regulation of DNA damage response WP1530,0.4473689233973712,1.2381676074685193,0.9959469743679834,"['CDKN1A', 'GADD45B', 'GADD45A']",0.7837557366458314,0,0,3
208,Small cell lung cancer WP4658,0.4518769451398403,1.1756749780599867,0.9338919889449802,"['CDKN1A', 'GADD45B', 'COL4A1', 'GADD45A']",0.7837557366458314,0,0,4
209,Wnt signaling pathway and pluripotency WP399,0.4518769451398403,1.1756749780599867,0.9338919889449802,"['WNT7B', 'PRKCQ', 'PRKCZ', 'CD44']",0.7837557366458314,0,0,4
210,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.4534124096298198,1.763020030816641,1.3944662841310735,['CCL2'],0.7837557366458314,0,0,1
211,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4603321639310123,1.212266156462585,0.9404845149884468,"['CDKN1A', 'PODXL', 'PLCE1']",0.7888436755956797,0,0,3
212,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.46281354561204285,1.1580258842075821,0.8921790576747027,"['SHC1', 'EGF', 'RPS6', 'NRG1']",0.7888436755956797,0,0,4
213,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.47031688181243336,1.2929258630447085,0.9753168080171656,"['CCL2', 'MAP3K14']",0.7888436755956797,0,0,2
214,IL-5 signaling pathway WP127,0.47031688181243336,1.2929258630447085,0.9753168080171656,"['SHC1', 'RPS6']",0.7888436755956797,0,0,2
215,Parkinson's disease pathway WP2371,0.47031688181243336,1.2929258630447085,0.9753168080171656,"['UBB', 'SNCA']",0.7888436755956797,0,0,2
216,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.47031688181243336,1.2929258630447085,0.9753168080171656,"['CDKN1A', 'JUNB']",0.7888436755956797,0,0,2
217,PI3K-Akt signaling pathway WP4172,0.47632548303990796,1.059977615379551,0.7861365011194732,"['EFNA1', 'CDKN1A', 'GNG3', 'GNG2', 'COL4A1', 'EGF', 'RPS6', 'SPP1', 'OSMR', 'EPHA2']",0.7888436755956797,0,0,10
218,Airway smooth muscle cell contraction WP4962,0.4802601991918601,1.6159604519774011,1.1851894147336626,['PPP1R14A'],0.7888436755956797,0,0,1
219,Canonical and non-canonical TGF-B signaling WP3874,0.4802601991918601,1.6159604519774011,1.1851894147336626,['LOXL2'],0.7888436755956797,0,0,1
220,miRNA targets in ECM and membrane receptors WP2911,0.4802601991918601,1.6159604519774011,1.1851894147336626,['COL4A1'],0.7888436755956797,0,0,1
221,Riboflavin and CoQ disorders WP5037,0.4802601991918601,1.6159604519774011,1.1851894147336626,['RFK'],0.7888436755956797,0,0,1
222,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5024441240384244,1.2119057724957556,0.8341194054605736,"['ACTA2', 'PAK3']",0.8146581102129214,0,0,2
223,Nephrotic syndrome WP4758,0.5024441240384244,1.2119057724957556,0.8341194054605736,"['PODXL', 'PLCE1']",0.8146581102129214,0,0,2
224,NAD+ metabolism WP3644,0.5057913728188227,1.4915254237288136,1.0166699681877587,['NAMPT'],0.8146581102129214,0,0,1
225,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5057913728188227,1.4915254237288136,1.0166699681877587,['ICAM1'],0.8146581102129214,0,0,1
226,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5107779537081869,1.1186224489795917,0.7515132872430502,"['GNG2', 'RPS6', 'MYL12B']",0.8146581102129214,0,0,3
227,Focal Adhesion WP306,0.5193813695847128,1.0359458328976263,0.6786655703067006,"['COL4A1', 'SHC1', 'EGF', 'ACTN1', 'SPP1', 'PAK3', 'MYL12B']",0.8146581102129214,0,0,7
228,Toll-like Receptor Signaling Pathway WP75,0.5229993975999607,1.097420100115518,0.7113202368860336,"['TOLLIP', 'IRF7', 'SPP1']",0.8146581102129214,0,0,3
229,Androgen receptor signaling pathway WP138,0.5266068335679535,1.0622855942685119,0.6812448725626489,"['CDKN1A', 'LIMK2', 'BAG1', 'DSTN']",0.8146581102129214,0,0,4
230,Sleep regulation WP3591,0.530070393136303,1.384866828087167,0.8790379373960652,['OXTR'],0.8146581102129214,0,0,1
231,Statin inhibition of cholesterol production WP430,0.530070393136303,1.384866828087167,0.8790379373960652,['APOC1'],0.8146581102129214,0,0,1
232,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.530070393136303,1.384866828087167,0.8790379373960652,['MDH1'],0.8146581102129214,0,0,1
233,Cholesterol Biosynthesis Pathway WP197,0.530070393136303,1.384866828087167,0.8790379373960652,['MSMO1'],0.8146581102129214,0,0,1
234,MAPK pathway in congenital thyroid cancer WP4928,0.530070393136303,1.384866828087167,0.8790379373960652,['SHC1'],0.8146581102129214,0,0,1
235,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5332860272101075,1.1404174573055028,0.7169774473715053,"['IRF7', 'CCL2']",0.8146581102129214,0,0,2
236,Proteasome Degradation WP183,0.5469298347457807,1.0573283858998144,0.6380286982992301,"['UBB', 'H2AFZ', 'PSMB9']",0.8146581102129214,0,0,3
237,TGF-beta Receptor Signaling WP560,0.5482089043971533,1.1077370846471015,0.6658594902022149,"['EGF', 'SPP1']",0.8146581102129214,0,0,2
238,Apoptosis Modulation by HSP70 WP384,0.5531585719040256,1.2924293785310734,0.7652610961283691,['HSPA1A'],0.8146581102129214,0,0,1
239,T-cell receptor (TCR) signaling pathway WP69,0.5586285356114151,1.038356413994169,0.6046043526056643,"['SHC1', 'PRKCQ', 'MAP3K14']",0.8146581102129214,0,0,3
240,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.562793933666328,1.0768722882475004,0.6190311320130113,"['PRKCQ', 'MAP3K14']",0.8146581102129214,0,0,2
241,Endochondral Ossification with Skeletal Dysplasias WP4808,0.562793933666328,1.0768722882475004,0.6190311320130113,"['ADAMTS1', 'SPP1']",0.8146581102129214,0,0,2
242,Endochondral Ossification WP474,0.562793933666328,1.0768722882475004,0.6190311320130113,"['ADAMTS1', 'SPP1']",0.8146581102129214,0,0,2
243,Glycogen Synthesis and Degradation WP500,0.562793933666328,1.0768722882475004,0.6190311320130113,"['CALM3', 'GYG2']",0.8146581102129214,0,0,2
244,IL-3 signaling pathway WP286,0.562793933666328,1.0768722882475004,0.6190311320130113,"['YWHAB', 'SHC1']",0.8146581102129214,0,0,2
245,Netrin-UNC5B signaling pathway WP4747,0.562793933666328,1.0768722882475004,0.6190311320130113,"['CCL2', 'ICAM1']",0.8146581102129214,0,0,2
246,Striated Muscle Contraction Pathway WP383,0.575114223371972,1.2115466101694916,0.670211360404619,['ACTA2'],0.8146581102129214,0,0,1
247,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.575114223371972,1.2115466101694916,0.670211360404619,['SHC1'],0.8146581102129214,0,0,1
248,Monoamine Transport WP727,0.575114223371972,1.2115466101694916,0.670211360404619,['IL1R1'],0.8146581102129214,0,0,1
249,NAD+ biosynthetic pathways WP3645,0.575114223371972,1.2115466101694916,0.670211360404619,['NAMPT'],0.8146581102129214,0,0,1
250,Splicing factor NOVA regulated synaptic proteins WP4148,0.5770382898170738,1.0476758592208508,0.5760610662008943,"['EPB41L3', 'PRKCZ']",0.8146581102129214,0,0,2
251,Metabolic reprogramming in colon cancer WP4290,0.5770382898170738,1.0476758592208508,0.5760610662008943,"['MDH2', 'PGAM1']",0.8146581102129214,0,0,2
252,Circadian rhythm related genes WP3594,0.5809568055972245,0.9768584356819651,0.5305111752255366,"['NFIL3', 'KCNH7', 'NAMPT', 'ID3', 'RPS27A', 'UBA52']",0.8146581102129214,0,0,6
253,Eukaryotic Transcription Initiation WP405,0.5909402364713493,1.0200160843534984,0.5365696582190009,"['POLR2I', 'POLR2K']",0.8146581102129214,0,0,2
254,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.5959928110339393,1.1401794616151546,0.5900732845477674,['MDH2'],0.8146581102129214,0,0,1
255,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5959928110339393,1.1401794616151546,0.5900732845477674,['IRF7'],0.8146581102129214,0,0,1
256,Zinc homeostasis WP3529,0.5959928110339393,1.1401794616151546,0.5900732845477674,['SLC39A14'],0.8146581102129214,0,0,1
257,Ebstein-Barr virus LMP1 signaling WP262,0.5959928110339393,1.1401794616151546,0.5900732845477674,['MAP3K14'],0.8146581102129214,0,0,1
258,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5959928110339393,1.1401794616151546,0.5900732845477674,['RPS6'],0.8146581102129214,0,0,1
259,Genes controlling nephrogenesis WP4823,0.5959928110339393,1.1401794616151546,0.5900732845477674,['ROBO2'],0.8146581102129214,0,0,1
260,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.5959928110339393,1.1401794616151546,0.5900732845477674,['ETV6'],0.8146581102129214,0,0,1
261,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5959928110339393,1.1401794616151546,0.5900732845477674,['MAP1LC3A'],0.8146581102129214,0,0,1
262,IL-18 signaling pathway WP4754,0.5994193249895439,0.9563983652033966,0.48947883403878434,"['ACTA2', 'SOCS3', 'NRN1', 'TMSB4X', 'STMN1', 'SPP1', 'CCL2', 'ICAM1']",0.8146581102129214,0,0,8
263,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6044990258277331,0.9937747594793436,0.5002217131478213,"['EGF', 'SPP1']",0.8146581102129214,0,0,2
264,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6044990258277331,0.9937747594793436,0.5002217131478213,"['PPP1R14A', 'MAP1LC3A']",0.8146581102129214,0,0,2
265,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6044990258277331,0.9937747594793436,0.5002217131478213,"['MAP1LC3A', 'CP']",0.8146581102129214,0,0,2
266,Cannabinoid receptor signaling WP3869,0.6158470863807803,1.0767419962335216,0.5219577704998158,['PRKAR2B'],0.8146581102129214,0,0,1
267,White fat cell differentiation WP4149,0.6158470863807803,1.0767419962335216,0.5219577704998158,['CEBPD'],0.8146581102129214,0,0,1
268,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6158470863807803,1.0767419962335216,0.5219577704998158,['RPS6'],0.8146581102129214,0,0,1
269,Hippo-Yap signaling pathway WP4537,0.6158470863807803,1.0767419962335216,0.5219577704998158,['NDRG1'],0.8146581102129214,0,0,1
270,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6158470863807803,1.0767419962335216,0.5219577704998158,['ATP2C2'],0.8146581102129214,0,0,1
271,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6158470863807803,1.0767419962335216,0.5219577704998158,['GRM1'],0.8146581102129214,0,0,1
272,Pre-implantation embryo WP3527,0.6158470863807803,1.0767419962335216,0.5219577704998158,['ZFP36'],0.8146581102129214,0,0,1
273,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.632978615734123,0.9221517958719324,0.42171720499493637,"['SHC1', 'TRIP10', 'IRS2', 'MAP3K6', 'MAP3K14']",0.8146581102129214,0,0,5
274,Sphingolipid Metabolism (general overview) WP4725,0.6347272215836988,1.0199821587867974,0.4636430336841348,['UGCG'],0.8146581102129214,0,0,1
275,Cell migration and invasion through p75NTR WP4561,0.6347272215836988,1.0199821587867974,0.4636430336841348,['EFNA1'],0.8146581102129214,0,0,1
276,Unfolded protein response WP4925,0.6347272215836988,1.0199821587867974,0.4636430336841348,['TXNIP'],0.8146581102129214,0,0,1
277,DNA Mismatch Repair WP531,0.6347272215836988,1.0199821587867974,0.4636430336841348,['POLE4'],0.8146581102129214,0,0,1
278,Endothelin Pathways WP2197,0.6347272215836988,1.0199821587867974,0.4636430336841348,['EDNRA'],0.8146581102129214,0,0,1
279,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6347272215836988,1.0199821587867974,0.4636430336841348,['CDKN1A'],0.8146581102129214,0,0,1
280,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6347272215836988,1.0199821587867974,0.4636430336841348,['CCL2'],0.8146581102129214,0,0,1
281,Nanoparticle triggered autophagic cell death WP2509,0.6347272215836988,1.0199821587867974,0.4636430336841348,['MAP1LC3A'],0.8146581102129214,0,0,1
282,Leptin signaling pathway WP2034,0.6351994847151372,0.9224165856818918,0.41860757152840483,"['SOCS3', 'SHC1', 'RPS6']",0.8146581102129214,0,0,3
283,Amino Acid metabolism WP3925,0.6453493361785929,0.9079241071428571,0.39763762180847506,"['WARS', 'MDH1', 'MDH2']",0.8146581102129214,0,0,3
284,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6453493361785929,0.9079241071428571,0.39763762180847506,"['EGF', 'NRG1', 'MAP3K14']",0.8146581102129214,0,0,3
285,Sphingolipid Metabolism (integrated pathway) WP4726,0.6526809351990953,0.9688983050847457,0.4133968196778412,['UGCG'],0.8146581102129214,0,0,1
286,TLR4 Signaling and Tolerance WP3851,0.6526809351990953,0.9688983050847457,0.4133968196778412,['IRF7'],0.8146581102129214,0,0,1
287,Wnt signaling in kidney disease WP4150,0.6526809351990953,0.9688983050847457,0.4133968196778412,['WNT7B'],0.8146581102129214,0,0,1
288,Photodynamic therapy-induced unfolded protein response WP3613,0.6526809351990953,0.9688983050847457,0.4133968196778412,['WARS'],0.8146581102129214,0,0,1
289,SARS-CoV-2 mitochondrial interactions WP5038,0.6526809351990953,0.9688983050847457,0.4133968196778412,['IRF7'],0.8146581102129214,0,0,1
290,Corticotropin-releasing hormone signaling pathway WP2355,0.6552978603373607,0.8938775510204081,0.37781111096098596,"['PRKCQ', 'JUNB', 'FOSL2']",0.8146581102129214,0,0,3
291,Glioblastoma signaling pathways WP2261,0.6552978603373607,0.8938775510204081,0.37781111096098596,"['CDKN1A', 'PRKCQ', 'PRKCZ']",0.8146581102129214,0,0,3
292,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6553172677194851,0.901014727366052,0.38080106427450094,"['IRF7', 'PIN1']",0.8146581102129214,0,0,2
293,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6697536121300218,0.9226795803066989,0.3698518445141593,['NDRG1'],0.8269406843646188,0,0,1
294,Oxidation by Cytochrome P450 WP43,0.6697536121300218,0.9226795803066989,0.3698518445141593,['CYP39A1'],0.8269406843646188,0,0,1
295,Rett syndrome causing genes WP4312,0.6787062131662214,0.8608187134502924,0.33362485814231113,"['SCN2A', 'GABRD']",0.8351537470486046,0,0,2
296,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6839448675963886,0.8603445012303615,0.32682592050939685,"['CLDN11', 'COL4A1', 'SHC1', 'WNT7B']",0.8384302879504588,0,0,4
297,Aryl Hydrocarbon Receptor Pathway WP2873,0.6859884174140117,0.8806625577812018,0.3319169057660128,['JUNB'],0.8384302879504588,0,0,1
298,Osteoblast differentiation WP4787,0.6930741691300353,0.841762792073351,0.3086056096218056,"['WNT7B', 'PRKCQ', 'PRKCZ']",0.8442480650812174,0,0,3
299,Sphingolipid pathway WP1422,0.7014264047474295,0.8422991893883567,0.29871239172162617,['UGCG'],0.8487259497443896,0,0,1
300,Oxysterols derived from cholesterol WP4545,0.7014264047474295,0.8422991893883567,0.29871239172162617,['CYP39A1'],0.8487259497443896,0,0,1
301,Notch Signaling Pathway Netpath WP61,0.7113438006774202,0.8068053197509903,0.2747974245996258,"['CDKN1A', 'HES5']",0.8550878383510899,0,0,2
302,Chemokine signaling pathway WP3929,0.7150934746695561,0.823444126282214,0.2761354092778853,"['GNG3', 'GNG2', 'SHC1', 'PRKCZ']",0.8550878383510899,0,0,4
303,BDNF-TrkB Signaling WP3676,0.7161066194455409,0.8071327683615819,0.2695227889429522,['SHC1'],0.8550878383510899,0,0,1
304,Resistin as a regulator of inflammation WP4481,0.7161066194455409,0.8071327683615819,0.2695227889429522,['PLCE1'],0.8550878383510899,0,0,1
305,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7300661968944087,0.7747796610169492,0.24376122984620513,['PRKCQ'],0.8660589198453279,0,0,1
306,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7300661968944087,0.7747796610169492,0.24376122984620513,['CALM3'],0.8660589198453279,0,0,1
307,mRNA Processing WP411,0.7343270900839048,0.8126595348036826,0.25094985174781015,"['SF3B5', 'SNRPN', 'SNRPD2', 'CELF4', 'SNU13']",0.8676288914140927,0,0,5
308,3q29 copy number variation syndrome WP4906,0.741160435724273,0.7591464429574886,0.22739333224158012,"['DYNLT3', 'DYNLL2']",0.8676288914140927,0,0,2
309,MET in type 1 papillary renal cell carcinoma WP4205,0.741160435724273,0.7591464429574886,0.22739333224158012,"['CDKN1A', 'PAK3']",0.8676288914140927,0,0,2
310,Base Excision Repair WP4752,0.743340455178465,0.7449152542372881,0.22094270041355113,['POLE4'],0.8676288914140927,0,0,1
311,Neural Crest Cell Migration during Development WP4564,0.743340455178465,0.7449152542372881,0.22094270041355113,['PAK3'],0.8676288914140927,0,0,1
312,Allograft Rejection WP2328,0.7559629846063587,0.717263025737602,0.2006635598725169,['PRKCZ'],0.8766401275291035,0,0,1
313,Regulation of toll-like receptor signaling pathway WP1449,0.7590911187932329,0.7537768354094885,0.20776611546382442,"['TOLLIP', 'IRF7', 'SPP1']",0.8766401275291035,0,0,3
314,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7679657315544212,0.6915859564164649,0.18258572398794892,['RPS6'],0.8766401275291035,0,0,1
315,Development of ureteric collection system WP5053,0.7679657315544212,0.6915859564164649,0.18258572398794892,['ROBO2'],0.8766401275291035,0,0,1
316,Fatty acid beta-oxidation WP143,0.7679657315544212,0.6915859564164649,0.18258572398794892,['TPI1'],0.8766401275291035,0,0,1
317,miRNA regulation of prostate cancer signaling pathways WP3981,0.7679657315544212,0.6915859564164649,0.18258572398794892,['CDKN1A'],0.8766401275291035,0,0,1
318,PDGFR-beta pathway WP3972,0.7679657315544212,0.6915859564164649,0.18258572398794892,['SHC1'],0.8766401275291035,0,0,1
319,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7793790790761044,0.6676797194623028,0.16642433042767782,['MAP1LC3A'],0.8841081428269558,0,0,1
320,Neural Crest Cell Migration in Cancer WP4565,0.7793790790761044,0.6676797194623028,0.16642433042767782,['PAK3'],0.8841081428269558,0,0,1
321,Neural Crest Differentiation WP2064,0.7849955639729794,0.691062333252486,0.1672904430940112,"['HES5', 'GFAP']",0.8877052639320608,0,0,2
322,Head and Neck Squamous Cell Carcinoma WP4674,0.7929382541369208,0.6788788609894856,0.15750663295320755,"['CDKN1A', 'RPS6']",0.8939024417754727,0,0,2
323,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8005517451971842,0.6244942591580098,0.1389213130840479,['NEFL'],0.8969144552672157,0,0,1
324,p38 MAPK Signaling Pathway WP400,0.8005517451971842,0.6244942591580098,0.1389213130840479,['SHC1'],0.8969144552672157,0,0,1
325,Integrated Cancer Pathway WP1971,0.8103646818142846,0.6049258474576271,0.1271983073229603,['CDKN1A'],0.9023385874189733,0,0,1
326,Phosphoinositides metabolism WP4971,0.8103646818142846,0.6049258474576271,0.1271983073229603,['PLCE1'],0.9023385874189733,0,0,1
327,Copper homeostasis WP3286,0.8196955898068258,0.5865434001027221,0.11661787242537346,['SOD1'],0.9099029402487171,0,0,1
328,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8221712517949841,0.63413955300732,0.12416869084404089,"['RPS6', 'PRKCQ']",0.9099029402487171,0,0,2
329,Ebola Virus Pathway on Host WP4217,0.8360902751613626,0.6514560880531988,0.11662281357653959,"['SOCS3', 'ACTN1', 'IRF7']",0.9151587771406149,0,0,3
330,Common Pathways Underlying Drug Addiction WP2636,0.8370047217925183,0.5529297820823245,0.09838034508737983,['GRM1'],0.9151587771406149,0,0,1
331,Notch Signaling WP268,0.8370047217925183,0.5529297820823245,0.09838034508737983,['HES5'],0.9151587771406149,0,0,1
332,PDGF Pathway WP2526,0.8370047217925183,0.5529297820823245,0.09838034508737983,['SHC1'],0.9151587771406149,0,0,1
333,Integrated breast cancer pathway WP1984,0.8512068337393753,0.6602309293961764,0.1063632899209411,"['ITPKC', 'GADD45A', 'FAU', 'FOSL2']",0.9266876008959297,0,0,4
334,Phosphodiesterases in neuronal function WP4222,0.8526547071604422,0.5229500687127806,0.08335856079639876,['PDE8B'],0.9266876008959297,0,0,1
335,ATM Signaling Network in Development and Disease  WP3878,0.8599077525639727,0.5091436217662801,0.07684512826985374,['CDK5R1'],0.9281710161900334,0,0,1
336,Regulation of Microtubule Cytoskeleton WP2038,0.8599077525639727,0.5091436217662801,0.07684512826985374,['STMN1'],0.9281710161900334,0,0,1
337,B Cell Receptor Signaling Pathway WP23,0.8645277537629227,0.5685109357834814,0.08275920034554177,"['BCL6', 'SHC1']",0.9281710161900334,0,0,2
338,Pathways in clear cell renal cell carcinoma WP4018,0.8645277537629227,0.5685109357834814,0.08275920034554177,"['TPI1', 'MDH1']",0.9281710161900334,0,0,2
339,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8668043374336675,0.496045197740113,0.07090569531969458,['RPS6'],0.9281710161900334,0,0,1
340,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8733619520843009,0.48360169491525423,0.0654821851245958,['CFL1'],0.9297078844768364,0,0,1
341,Pathogenic Escherichia coli infection WP2272,0.8733619520843009,0.48360169491525423,0.0654821851245958,['ARPC5L'],0.9297078844768364,0,0,1
342,Nucleotide Excision Repair WP4753,0.8795972302260637,0.47176519222819346,0.06052330810268136,['POLE4'],0.933607586468015,0,0,1
343,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8855259905413705,0.46049233252623084,0.05598365120152731,['GRM1'],0.9371601590860568,0,0,1
344,Integrin-mediated Cell Adhesion WP185,0.8888927933162083,0.5293392562271786,0.062344859383150854,"['SHC1', 'PAK3']",0.9376587520224994,0,0,2
345,RANKL/RANK signaling pathway WP2018,0.8911632767155987,0.44974379188017344,0.05182290549605535,['ICAM1'],0.9376587520224994,0,0,1
346,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8965233952775896,0.4394838212634823,0.04800520895443977,['WNT7B'],0.9405722326178179,0,0,1
347,ESC Pluripotency Pathways WP3931,0.9014942802746688,0.5083102493074793,0.052712576509379334,"['EGF', 'WNT7B']",0.9430617398838754,0,0,2
348,Translation Factors WP107,0.9110734986887418,0.4113234763793725,0.0383072570093579,['EEF1B2'],0.9503439081149807,0,0,1
349,Hepatitis B infection WP4666,0.9233780916254299,0.5213274498988785,0.04155839703192575,"['CDKN1A', 'YWHAB', 'IRF7']",0.9604190465903468,0,0,3
350,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9273463562435599,0.37892987703555997,0.028581980312506673,['STMN1'],0.9607994494131047,0,0,1
351,AMP-activated protein kinase (AMPK) signaling WP1403,0.9309268373376166,0.3716101694915254,0.026597845455206336,['CDKN1A'],0.9607994494131047,0,0,1
352,Apoptosis WP254,0.934331145021559,0.36456667732651105,0.024762957723809795,['IRF7'],0.9607994494131047,0,0,1
353,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.934331145021559,0.36456667732651105,0.024762957723809795,['WNT7B'],0.9607994494131047,0,0,1
354,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9539044680458467,0.3218361581920904,0.015188011796669084,['MDH1'],0.9744457078588891,0,0,1
355,Endoderm differentiation WP2853,0.9549901778597081,0.4059690822982754,0.018696590857543383,"['TCEAL2', 'NME1']",0.9744457078588891,0,0,2
356,Mesodermal commitment pathway WP2857,0.9568453293870418,0.40170486700622526,0.01772061603681906,"['ARL4A', 'RPL38']",0.9744457078588891,0,0,2
357,DNA IR-damage and cellular response via ATR WP4016,0.9583391672331224,0.3113996719518863,0.013251154313854265,['BCL6'],0.9744457078588891,0,0,1
358,Ciliary landscape WP4352,0.9689969580857615,0.49779836955560663,0.01567756544052062,"['DYNLT3', 'NEFL', 'COX6C', 'DYNLL2', 'MAPRE2']",0.9825304351539983,0,0,5
359,22q11.2 copy number variation syndrome WP4657,0.9761230285727919,0.2642210355235663,0.0063853364023610075,['ACTA2'],0.9838430890668018,0,0,1
360,Wnt signaling WP428,0.9773018008215011,0.26062757672927167,0.005983948953970305,['WNT7B'],0.9838430890668018,0,0,1
361,Male infertility WP4673,0.978422465986544,0.25712994350282486,0.005608963910170528,['SOD2'],0.9838430890668018,0,0,1
362,Thermogenesis WP4321,0.98699797281186,0.2266799601196411,0.002966627154930321,['RPS6'],0.9897244865489092,0,0,1
363,DNA Repair Pathways Full Network WP4946,0.9947805646400566,0.18676978772420602,0.0009773857597939104,['POLE4'],0.9947805646400566,0,0,1
